A Review of the Medicinal Importance and Perspectives of the 2-isoxazoline Scaffold

References

1. Anand K. Wakode S. Development of drugs based on benzimidazole heterocycle: Recent advancement and insights. Int. J. Chem. Stud. 2017 5 350 362
   [Google Scholar]
2. Katritzky A.R. Ramsden C.A. Scriven E.F.V. Taylor R.J.K. Comprehensive Heterocyclic Chemistry III Elsevier 2008 14 ed 10.1016/C2009‑1‑28335‑3
   [Google Scholar]
3. Jain S. Chandra V. Kumar Jain P. Pathak K. Pathak D. Vaidya A. Comprehensive review on current developments of quinoline-based anticancer agents. Arab. J. Chem. 2019 12 8 4920 4946 10.1016/j.arabjc.2016.10.009
   [Google Scholar]
4. Barbier T. Barbry A. Magand J. Badiou C. Davy F. Baudouin A. Queneau Y. Dumitrescu O. Lina G. Soulère L. Synthesis and biological evaluation of benzo[b]thiophene acylhydrazones as antimicrobial agents against multidrug-resistant Staphylococcus aureus. Biomolecules 2022 12 1 131 10.3390/biom12010131 35053281
   [Google Scholar]
5. Keri R.S. Chand K. Budagumpi S. Balappa Somappa S. Patil S.A. Nagaraja B.M. An overview of benzo [b] thiophene-based medicinal chemistry. Eur. J. Med. Chem. 2017 138 1002 1033 10.1016/j.ejmech.2017.07.038 28759875
   [Google Scholar]
6. Ghorab M. El-Gazzar M. Alsaid M. Synthesis, characterization and anti-breast cancer activity of new 4-aminoantipyrine-based heterocycles. Int. J. Mol. Sci. 2014 15 5 7539 7553 10.3390/ijms15057539 24798749
   [Google Scholar]
7. Kumar G. Shankar R. 2‐isoxazolines: A synthetic and medicinal overview. ChemMedChem 2021 16 3 430 447 10.1002/cmdc.202000575 33029886
   [Google Scholar]
8. Yadav P. Shah K. Chemistry and biological evaluation of pyrido[4,3‐ d]pyrimidines: A review. Chem. Biol. Drug Des. 2022 99 5 758 768 10.1111/cbdd.14026 35152554
   [Google Scholar]
9. Yadav P. Shah K. Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry. Bioorg. Chem. 2021 109 104639 10.1016/j.bioorg.2021.104639 33618829
   [Google Scholar]
10. Agrawal N. Mishra R. Pathak S. Goyal A. Shah K. Hydrazides and hydrazones: Robust scaffolds in neurological and neurodegenerative disorders. Lett. Org. Chem. 2023 20 2 123 136 10.2174/1570178619666220831122614
    [Google Scholar]
11. Agrawal N. Mishra P. Novel isoxazole derivatives as potential antiparkinson agents: Synthesis, evaluation of monoamine oxidase inhibitory activity and docking studies. Med. Chem. Res. 2019 28 9 1488 1501 10.1007/s00044‑019‑02388‑4
    [Google Scholar]
12. Agrawal N. Mishra P. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents. Comput. Biol. Chem. 2019 79 63 72 10.1016/j.compbiolchem.2019.01.012 30731360
    [Google Scholar]
13. Agrawal N. Mishra P. The synthetic and therapeutic expedition of isoxazole and its analogs. Med. Chem. Res. 2018 27 5 1309 1344 10.1007/s00044‑018‑2152‑6 32214770
    [Google Scholar]
14. Zhou X. Hohman A.E. Hsu W.H. Current review of isoxazoline ectoparasiticides used in veterinary medicine. J. Vet. Pharmacol. Ther. 2022 45 1 1 15 10.1111/jvp.12959 33733534
    [Google Scholar]
15. Wang X. Hu Q. Tang H. Pan X. Isoxazole/isoxazoline skeleton in the structural modification of natural products: A review. Pharmaceuticals (Basel) 2023 16 2 228 10.3390/ph16020228 37259376
    [Google Scholar]
16. Alshamari A. Al-Qudah M. Hamadeh F. Al-Momani L. Abu-Orabi S. Synthesis, antimicrobial and antioxidant activities of 2-isoxazoline derivatives. Molecules 2020 25 18 4271 10.3390/molecules25184271 32961855
    [Google Scholar]
17. Das P. Hasan M.H. Mitra D. Bollavarapu R. Valente E.J. Tandon R. Raucher D. Hamme A.T. Design, synthesis, and preliminary studies of spiro-isoxazoline-peroxides against human cytomegalovirus and glioblastoma. J. Org. Chem. 2019 84 11 6992 7006 10.1021/acs.joc.9b00746 31066280
    [Google Scholar]
18. Gul M. Eryılmaz S. Synthesis, antioxidant activity and theoretical investigation of isoxazolines derivatives of monoterpenoids. Lett. Org. Chem. 2019 16 6 501 510 10.2174/1570178616666181226154540
    [Google Scholar]
19. Kaur K. Kumar V. Sharma A.K. Gupta G.K. Isoxazoline containing natural products as anticancer agents: A review. Eur. J. Med. Chem. 2014 77 121 133 10.1016/j.ejmech.2014.02.063 24631731
    [Google Scholar]
20. Arya G.C. Kaur K. Jaitak V. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies. Eur. J. Med. Chem. 2021 221 113511 10.1016/j.ejmech.2021.113511 34000484
    [Google Scholar]
21. Tilvi S. Singh K.S. Synthesis of oxazole, oxazoline and isoxazoline derived marine natural products: A review. Curr. Org. Chem. 2016 20 898 929 10.2174/1385272819666150804000046
    [Google Scholar]
22. Pandhurnekar C.P. Pandhurnekar H.C. Mungole A.J. Butoliya S.S. Yadao B.G. A review of recent synthetic strategies and biological activities of isoxazole. J. Heterocycl. Chem. 2023 60 4 537 565 10.1002/jhet.4586
    [Google Scholar]
23. Aarjane M. Slassi S. Ghaleb A. Tazi B. Amine A. Synthesis, biological evaluation, molecular docking and in silico ADMET screening studies of novel isoxazoline derivatives from acridone. Arab. J. Chem. 2021 14 4 103057 10.1016/j.arabjc.2021.103057
    [Google Scholar]
24. Abu-Hashem A.A. El-Shazly M. Synthesis of new isoxazole-, pyridazine-, pyrimidopyrazines and their anti-inflammatory and analgesic activity. Med. Chem. 2018 14 4 356 371 10.2174/1573406414666180112110947 29332598
    [Google Scholar]
25. Kallitsakis M.G. Carotti A. Catto M. Peperidou A. Hadjipavlou-Litina D.J. Litinas K.E. Synthesis and biological evaluation of novel hybrid molecules containing purine, coumarin and isoxazoline or isoxazole moieties. Open Med. Chem. J. 2017 11 1 196 211 10.2174/1874104501711010196 29387274
    [Google Scholar]
26. Znati M. Debbabi M. Romdhane A. Ben Jannet H. Bouajila J. Synthesis of new anticancer and anti-inflammatory isoxazolines and aziridines from the natural (-)-deltoin. J. Pharm. Pharmacol. 2018 70 12 1700 1712 10.1111/jphp.13013 30229910
    [Google Scholar]
27. Bano S. Alam M.S. Javed K. Dudeja M. Das A.K. Dhulap A. Synthesis, biological evaluation and molecular docking of some substituted pyrazolines and isoxazolines as potential antimicrobial agents. Eur. J. Med. Chem. 2015 95 96 103 10.1016/j.ejmech.2015.03.031 25800645
    [Google Scholar]
28. Kumari P. Mishra V.S. Narayana C. Khanna A. Chakrabarty A. Sagar R. Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents. Sci. Rep. 2020 10 1 6660 10.1038/s41598‑020‑63377‑x 32313038
    [Google Scholar]
29. Reddy S.T. Mendonza J.J. Makani V.K.K. Bhadra M.P. Uppuluri V.M. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell. Bioorg. Chem. 2020 105 104374 10.1016/j.bioorg.2020.104374 33130349
    [Google Scholar]
30. Huang S. Zhu B. Wang K. Yu M. Wang Z. Li Y. Liu Y. Zhang P. Li S. Li Y. Liu A. Wang Q. Design, synthesis, and insecticidal and fungicidal activities of quaternary ammonium salt derivatives of a triazolyphenyl isoxazoline insecticide. Pest Manag. Sci. 2022 78 5 2011 2021 10.1002/ps.6824 35118797
    [Google Scholar]
31. Chalkha M. Nour H. Chebbac K. Nakkabi A. Bahsis L. Bakhouch M. Akhazzane M. Bourass M. Chtita S. Bin Jardan Y.A. Augustyniak M. Bourhia M. Aboul-Soud M.A.M. El Yazidi M. Synthesis, characterization, DFT Mechanistic study, antimicrobial activity, molecular modeling, and ADMET properties of novel pyrazole-isoxazoline hybrids. ACS Omega 2022 7 50 46731 46744 10.1021/acsomega.2c05788 36570248
    [Google Scholar]
32. Zaki Y.H. Sayed A.R. Elroby S.A. Regioselectivity of 1,3-dipolar cycloadditions and antimicrobial activity of isoxazoline, pyrrolo[3,4-d]isoxazole-4,6-diones, pyrazolo[3,4-d]pyridazines and pyrazolo[1,5-a]pyrimidines. Chem. Cent. J. 2016 10 1 17 10.1186/s13065‑016‑0163‑2 27042207
    [Google Scholar]
33. Dadiboyena S. Arfaoui A. Amri H. Piedrafita F.J. Nefzi A. Diversity oriented synthesis and IKK inhibition of aminobenzimidazole tethered quinazoline-2,4-diones, thioxoquinazolin-4-ones, benzodiazepine-2,3,5-triones, isoxazoles and isoxazolines. Bioorg. Med. Chem. Lett. 2015 25 3 685 689 10.1016/j.bmcl.2014.11.078 25522820
    [Google Scholar]
34. Yang R. Zhang Y. Xu H. Synthesis of novel isoxazoline-containing podophyllotoxin/2′(2′,6′)-(di)halogenopodophyllotoxin derivatives and their insecticidal/acaricidal activities. Bioorg. Med. Chem. Lett. 2018 28 8 1410 1416 10.1016/j.bmcl.2018.02.018 29548577
    [Google Scholar]
35. Ismail T. Shafi S. Singh S. Sidiq T. Khajuria A. Rouf A. Yadav M. Saikam V. Singh P.P. Alam M.S. Islam N. Sharma K. Kumar H.M.S. Synthesis and immunopotentiating activity of novel isoxazoline functionalized coumarins. Eu. J. Med. Chem. 2016 123 90 104 10.1016/j.ejmech.2016.07.026
    [Google Scholar]
36. Puttaswamy N. Pavan Kumar G.S. Al-Ghorbani M. Vigneshwaran V. Prabhakar B.T. Khanum S.A. Synthesis and biological evaluation of salicylic acid conjugated isoxazoline analogues on immune cell proliferation and angiogenesis. Eur. J. Med. Chem. 2016 114 153 161 10.1016/j.ejmech.2016.02.052 26974382
    [Google Scholar]
37. Das P. Boone S. Mitra D. Turner L. Tandon R. Raucher D. Hamme A.T. Synthesis and biological evaluation of fluoro-substituted spiro-isoxazolines as potential anti-viral and anti-cancer agents. RSC Advances 2020 10 50 30223 30237 10.1039/D0RA06148D 35518245
    [Google Scholar]
38. Ghosh A.K. Ghosh K. Brindisi M. Lendy E.K. Yen Y.C. Kumaragurubaran N. Huang X. Tang J. Mesecar A.D. Design, synthesis, X-ray studies, and biological evaluation of novel BACE1 inhibitors with bicyclic isoxazoline carboxamides as the P3 ligand. Bioorg. Med. Chem. Lett. 2018 28 15 2605 2610 10.1016/j.bmcl.2018.06.045 29970308
    [Google Scholar]
39. Gini A. Segler M. Kellner D. Mancheño O.G. Dehydrogenative TEMPO‐mediated formation of unstable nitrones: Easy access to N‐carbamoyl isoxazolines. Chemistry 2015 21 34 12053 12060 10.1002/chem.201501314 26212677
    [Google Scholar]
40. Liu X. Hong D. Sapir N.G. Yang W. Hersh W.H. Leung P.H. Yang D. Chen Y. Iron-catalyzed transfer hydrogenation in aged N-methyl-2-pyrrolidone: Reductive ring-opening of 3,5-disubstituted isoxazoles and isoxazolines. J. Org. Chem. 2019 84 24 16204 16213 10.1021/acs.joc.9b02733 31790236
    [Google Scholar]
41. Zeng Z.G. Liu N. Lin F. Jiang X.Y. Xu H.H. Synthesis and antiphytoviral activity of α-aminophosphonates containing 3, 5-diphenyl-2-isoxazoline as potential papaya ringspot virus inhibitors. Mol. Divers. 2019 23 2 393 401 10.1007/s11030‑018‑9877‑5 30306393
    [Google Scholar]
42. Rasool F. Nayak D. Katoch A. Faheem M.M. Yousuf S.K. Hussain N. Belawal C. Satti N.K. Goswami A. Mukherjee D. Regiospecific synthesis of ring a fused withaferin a isoxazoline analogues: Induction of premature senescence by W-2b in proliferating cancer cells. Sci. Rep. 2017 7 1 13749 10.1038/s41598‑017‑13664‑x 29062040
    [Google Scholar]
43. Sedenkova K.N. Andriasov K.S. Eremenko M.G. Grishin Y.K. Alferova V.A. Baranova A.A. Zefirov N.A. Zefirova O.N. Zarubaev V.V. Gracheva Y.A. Milaeva E.R. Averina E.B. Bicyclic isoxazoline derivatives: Synthesis and evaluation of biological activity. Molecules 2022 27 11 3546 10.3390/molecules27113546 35684482
    [Google Scholar]
44. Quadrelli P. Vazquez Martinez N. Scrocchi R. Corsaro A. Pistarà V. Syntheses of isoxazoline-carbocyclic nucleosides and their antiviral evaluation: A standard protocol. ScientificWorldJournal 2014 2014 492178 10.1155/2014/492178 25544956
    [Google Scholar]
45. Byrappa S. Harsha Raj M. Kungyal T. Kudva N N.U. Salimath B.P. Lokanatha Rai K.M. Synthesis and biological evaluation of novel isoxazolines linked via piperazine to 2- benzoisothiazoles as potent apoptotic agents. Eur. J. Med. Chem. 2017 126 218 224 10.1016/j.ejmech.2016.09.094 27821324
    [Google Scholar]
46. Yu M. Liu G. Zhang Y. Feng T. Xu M. Xu H. Design, synthesis and evaluation of novel isoxazolines/oxime sulfonates of 2′(2′,6′)-(Di)chloropodophyllotoxins as insecticidal agents. Sci. Rep. 2016 6 1 33062 10.1038/srep33062
    [Google Scholar]
47. Asahi M. Kobayashi M. Kagami T. Nakahira K. Furukawa Y. Ozoe Y. Fluxametamide: A novel isoxazoline insecticide that acts via distinctive antagonism of insect ligand-gated chloride channels. Pestic. Biochem. Physiol. 2018 151 67 72 10.1016/j.pestbp.2018.02.002 30704715
    [Google Scholar]
48. Ghidini E. Capelli A.M. Carnini C. Cenacchi V. Marchini G. Virdis A. Italia A. Facchinetti F. Discovery of a novel isoxazoline derivative of prednisolone endowed with a robust anti-inflammatory profile and suitable for topical pulmonary administration. Steroids 2015 95 88 95 10.1016/j.steroids.2014.12.016 25556984
    [Google Scholar]
49. Zhang T. Dong M. Zhao J. Zhang X. Mei X. Synthesis and antifungal activity of novel pyrazolines and isoxazolines derived from cuminaldehyde. J. Pestic. Sci. 2019 44 3 181 185 10.1584/jpestics.D19‑028 31530976
    [Google Scholar]
50. Huang M. Suk D.H. Cho N.C. Bhattarai D. Kang S.B. Kim Y. Pae A.N. Rhim H. Keum G. Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists. Bioorg. Med. Chem. Lett. 2015 25 7 1546 1551 10.1016/j.bmcl.2015.02.012 25765911
    [Google Scholar]
51. D’Ascenzio M. Secci D. Carradori S. Zara S. Guglielmi P. Cirilli R. Pierini M. Poli G. Tuccinardi T. Angeli A. Supuran C.T. 1,3-dipolar cycloaddition, HPLC enantioseparation, and docking studies of saccharin/isoxazole and saccharin/isoxazoline derivatives as selective carbonic anhydrase IX and XII inhibitors. J. Med. Chem. 2020 63 5 2470 2488 10.1021/acs.jmedchem.9b01434 31972093
    [Google Scholar]